Lactate Efflux Inhibition by Syrosingopine/LOD Co‐Loaded Nanozyme for Synergetic Self‐Replenishing Catalytic Cancer Therapy and Immune Microenvironment Remodeling

An effective systemic mechanism regulates tumor development and progression; thus, a rational design in a one‐stone‐two‐birds strategy is meant for cancer treatment. Herein, a hollow Fe(3)O(4) catalytic nanozyme carrier co‐loading lactate oxidase (LOD) and a clinically‐used hypotensor syrosingopine...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Shengming, Xu, Lehua, He, Chenlong, Wang, Peng, Qin, Jingwen, Guo, Fangfang, Wang, Yilong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502866/
https://www.ncbi.nlm.nih.gov/pubmed/37386815
http://dx.doi.org/10.1002/advs.202300686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502866/
https://www.ncbi.nlm.nih.gov/pubmed/37386815
http://dx.doi.org/10.1002/advs.202300686

Ejemplares similares